← All organizations

Averitas Pharma

Averitas Pharma

For profit

Also known as: AVERITAS | Averitas Pharma, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jun 5, 2025

Acquired by Grunenthal on Nov 14, 2018

Timeline

2000s

Nov 16, 2009
capsaicin— NDA Secondary Org

2010s

Sep 16, 2014
naloxegol— Marketing Organization
Jan 1, 2018
Averitas Pharma— Founded
Nov 14, 2018
Grunenthal— Acquired By

Drugs by trial phase (1 distinct, 2 trials)

Phase 3 (1 own, 0 via acquisition)

capsaicin

Marketed drugs (2)

Recent trials (2)

NCT06744816CollaboratorEarly Phase 1Jun 5, 2025
NCT04967664Lead sponsorPhase 3Jul 31, 2021

Details

Founded: Morristown, NJ, US Jan 1, 2018
Last known activity: Jun 5, 2025